Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease

Ava K. Kiser, Derek Mladenovich, Fariba Eshraghi, Debra Bourdeau, Gislin Dagnelie

Research output: Contribution to journalArticle

Abstract

Purpose. The purpose of this article is to establish reliability of standard visual function measures in patients with severe vision loss. Methods. Legally blind subjects were enrolled in a repeated-measures study to determine the reproducibility of a battery of psychophysical vision measures. Tests reported here include ETDRS visual acuity (VA) under regular and dim illumination and Pelli-Robson letter contrast sensitivity (CS) under regular, dim, and glare conditions. Two to five test repetitions were performed at monthly intervals. Subject groups included retinitis pigmentosa (RP) (n = 29), macular disease (MD) (n = 17), optic nerve disease (ON) (n = 4), diabetic retinopathy (DR) (n = 5), and other retinal diseases (OR) (n = 10). Results. For most subject groups, VA measures had mean 95% coefficient of repeatability (CR.95) of 0.20 (group means between 0.13 and 0.36) log units, and CS measures had mean CR.95 of 0.35 (group means between 0.19 and 0.48) log units. Conclusions. The established reliability of VA and CS tests in subjects with severe visual impairments will allow investigators to determine whether a significant change in vision has occurred during future clinical trials to reverse, halt, or slow vision loss. The criterion for change needs to be larger than for normally sighted controls, i.e., approximately two to three lines for VA and between eight to 11 letters for CS.

Original languageEnglish (US)
Pages (from-to)946-954
Number of pages9
JournalOptometry and Vision Science
Volume82
Issue number11
DOIs
StatePublished - Nov 2005

Fingerprint

Contrast Sensitivity
Eye Diseases
Visual Acuity
Glare
Retinal Diseases
Optic Nerve Diseases
Vision Disorders
Diabetic Retinopathy
Lighting
Research Personnel
Clinical Trials

Keywords

  • Contrast sensitivity
  • Glare
  • Low vision
  • Outcome
  • Psychophysics
  • Test-retest reliability
  • Validity
  • Visual acuity

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease. / Kiser, Ava K.; Mladenovich, Derek; Eshraghi, Fariba; Bourdeau, Debra; Dagnelie, Gislin.

In: Optometry and Vision Science, Vol. 82, No. 11, 11.2005, p. 946-954.

Research output: Contribution to journalArticle

Kiser, Ava K. ; Mladenovich, Derek ; Eshraghi, Fariba ; Bourdeau, Debra ; Dagnelie, Gislin. / Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease. In: Optometry and Vision Science. 2005 ; Vol. 82, No. 11. pp. 946-954.
@article{c7f6baf172894e01a8a867f2bc062bdd,
title = "Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease",
abstract = "Purpose. The purpose of this article is to establish reliability of standard visual function measures in patients with severe vision loss. Methods. Legally blind subjects were enrolled in a repeated-measures study to determine the reproducibility of a battery of psychophysical vision measures. Tests reported here include ETDRS visual acuity (VA) under regular and dim illumination and Pelli-Robson letter contrast sensitivity (CS) under regular, dim, and glare conditions. Two to five test repetitions were performed at monthly intervals. Subject groups included retinitis pigmentosa (RP) (n = 29), macular disease (MD) (n = 17), optic nerve disease (ON) (n = 4), diabetic retinopathy (DR) (n = 5), and other retinal diseases (OR) (n = 10). Results. For most subject groups, VA measures had mean 95{\%} coefficient of repeatability (CR.95) of 0.20 (group means between 0.13 and 0.36) log units, and CS measures had mean CR.95 of 0.35 (group means between 0.19 and 0.48) log units. Conclusions. The established reliability of VA and CS tests in subjects with severe visual impairments will allow investigators to determine whether a significant change in vision has occurred during future clinical trials to reverse, halt, or slow vision loss. The criterion for change needs to be larger than for normally sighted controls, i.e., approximately two to three lines for VA and between eight to 11 letters for CS.",
keywords = "Contrast sensitivity, Glare, Low vision, Outcome, Psychophysics, Test-retest reliability, Validity, Visual acuity",
author = "Kiser, {Ava K.} and Derek Mladenovich and Fariba Eshraghi and Debra Bourdeau and Gislin Dagnelie",
year = "2005",
month = "11",
doi = "10.1097/01.opx.0000187863.12609.7b",
language = "English (US)",
volume = "82",
pages = "946--954",
journal = "Optometry and Vision Science",
issn = "1040-5488",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease

AU - Kiser, Ava K.

AU - Mladenovich, Derek

AU - Eshraghi, Fariba

AU - Bourdeau, Debra

AU - Dagnelie, Gislin

PY - 2005/11

Y1 - 2005/11

N2 - Purpose. The purpose of this article is to establish reliability of standard visual function measures in patients with severe vision loss. Methods. Legally blind subjects were enrolled in a repeated-measures study to determine the reproducibility of a battery of psychophysical vision measures. Tests reported here include ETDRS visual acuity (VA) under regular and dim illumination and Pelli-Robson letter contrast sensitivity (CS) under regular, dim, and glare conditions. Two to five test repetitions were performed at monthly intervals. Subject groups included retinitis pigmentosa (RP) (n = 29), macular disease (MD) (n = 17), optic nerve disease (ON) (n = 4), diabetic retinopathy (DR) (n = 5), and other retinal diseases (OR) (n = 10). Results. For most subject groups, VA measures had mean 95% coefficient of repeatability (CR.95) of 0.20 (group means between 0.13 and 0.36) log units, and CS measures had mean CR.95 of 0.35 (group means between 0.19 and 0.48) log units. Conclusions. The established reliability of VA and CS tests in subjects with severe visual impairments will allow investigators to determine whether a significant change in vision has occurred during future clinical trials to reverse, halt, or slow vision loss. The criterion for change needs to be larger than for normally sighted controls, i.e., approximately two to three lines for VA and between eight to 11 letters for CS.

AB - Purpose. The purpose of this article is to establish reliability of standard visual function measures in patients with severe vision loss. Methods. Legally blind subjects were enrolled in a repeated-measures study to determine the reproducibility of a battery of psychophysical vision measures. Tests reported here include ETDRS visual acuity (VA) under regular and dim illumination and Pelli-Robson letter contrast sensitivity (CS) under regular, dim, and glare conditions. Two to five test repetitions were performed at monthly intervals. Subject groups included retinitis pigmentosa (RP) (n = 29), macular disease (MD) (n = 17), optic nerve disease (ON) (n = 4), diabetic retinopathy (DR) (n = 5), and other retinal diseases (OR) (n = 10). Results. For most subject groups, VA measures had mean 95% coefficient of repeatability (CR.95) of 0.20 (group means between 0.13 and 0.36) log units, and CS measures had mean CR.95 of 0.35 (group means between 0.19 and 0.48) log units. Conclusions. The established reliability of VA and CS tests in subjects with severe visual impairments will allow investigators to determine whether a significant change in vision has occurred during future clinical trials to reverse, halt, or slow vision loss. The criterion for change needs to be larger than for normally sighted controls, i.e., approximately two to three lines for VA and between eight to 11 letters for CS.

KW - Contrast sensitivity

KW - Glare

KW - Low vision

KW - Outcome

KW - Psychophysics

KW - Test-retest reliability

KW - Validity

KW - Visual acuity

UR - http://www.scopus.com/inward/record.url?scp=28844444929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28844444929&partnerID=8YFLogxK

U2 - 10.1097/01.opx.0000187863.12609.7b

DO - 10.1097/01.opx.0000187863.12609.7b

M3 - Article

C2 - 16317369

AN - SCOPUS:28844444929

VL - 82

SP - 946

EP - 954

JO - Optometry and Vision Science

JF - Optometry and Vision Science

SN - 1040-5488

IS - 11

ER -